Top

RESEARCH | QUALITY | RELIABILITY


COMPANY OVERVIEW

Anuh Pharma Ltd., a Bulk Drugs Manufacturing Company is part of the INR 8.5 bn SK Group of Companies, which employs 2000+ people across businesses such as Manufacturing of API's, Pharma Formulations, Distribution and Logistics.

Established in 1960, Anuh Pharma Ltd. today is one of the largest manufacturers of Macrolides and Anti-TB products in India, besides being a major player in Anti-Bacterials, Anti-Malarial, and Corticosteroids.

Anuh Pharma Ltd. continues to grow everyday thanks to the confidence our clients, employees and shareholders have in us. .

TIMELINE HISTORY

2024
Listed on the National Stock Exchange (NSE)

2024
4th Capacity Expansion of 400 MTPA for a Total Capacity of 2200 MTPA

2024
Successfully passed WHO-PQ Inspection from WHO - Geneva

2019
Successfully Passed USFDA Inspection

2019
Successfully Passed EDQM, Eu-GMP and WHO - PQ Joint Inspection

2019
Inaugurated New Expansion with a Additional Capacity of 900 MTPA for 20 Different Products

2017
Received Consent to Establish for Additional Capacity of 2000 MTPA for 20 Different Products

2016
Renewal of Eu-GMP & CEP for Erythromycin, Erythromycin Ethyl Succinate & Pyrazinamide

2015
Received WHO - PQ for Sulfadoxine

2014
Approval from COFEPRIS - Mexico for Erythromycin Estolate, Erythromycin Stearate, Erythromycin Ethyl Succinate

2013
Renewal of Eu-GMP & CEP for Erythromycin, Erythromycin Ethyl Succinate & Pyrazinamide

2012
Received WHO - PQ for Pyrazinamide & Acquired R&D Assets in Mahape, Navi Mumbai & got DSIR Approval

2010
Received Eu-GMP & CEP for Erythromycin, Erythromycin Ethyl Succinate & Pyrazinamide

2006
Doubled Capacity to 600 MTPA

1995
Doubled Capacity to 300 MTPA

1989
Commenced Manufacturing of Erythromycin Salts with Capacity of 150 MTPA

1960
Year of Establishment & Registration on Bombay Stock Exchange

STOCK INFORMATION
>